logo

GANX

Gain Therapeutics·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-03-28
4.92 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Is GANX a Buy, Sell, or Hold?
  • Based on a composite score of 4.92/10, we rate GANX as a Netural. Our analysis breaks down into 4.94/10 for Fundamentals, 2.88/10 for Technicals, and 5.92/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is GANX undervalued or overvalued?
Technical Analysis of GANX?
What is the analyst consensus for GANX?